Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
- 12 July 2021
- Vol. 71 (6), 1176-1191
- https://doi.org/10.1136/gutjnl-2021-324339
Abstract
Objective Hepatocellular carcinoma (HCC) tumour microenvironment (TME) is highly complex with diverse cellular components organising into various functional units, cellular neighbourhoods (CNs). And we wanted to define CN of HCC while preserving the TME architecture, based on which, potential targets for novel immunotherapy could be identified. Design A highly multiplexed imaging mass cytometry (IMC) panel was designed to simultaneously quantify 36 biomarkers of tissues from 134 patients with HCC and 7 healthy donors to generate 562 highly multiplexed histology images at single-cell resolution. Different function units were defined by topological analysis of TME. CN relevant to the patients’ prognosis was identified as specific target for HCC therapy. Transgenic mouse models were used to validate the novel immunotherapy target for HCC. Results Three major types of intratumour areas with distinct distribution patterns of tumorous, stromal and immune cells were identified. 22 cellular metaclusters and 16 CN were defined. CN composed of various types of cells formed regional function units and the regional immunity was regulated reversely by resident Kupffer cells and infiltrating macrophages with protumour and antitumour function, respectively. Depletion of Kupffer cells in mouse liver largely enhances the T cell response, reduces liver tumour growth and sensitises the tumour response to antiprogrammed cell death protein-1 treatment. Conclusion Our findings reveal for the first time the various topological function units of HCC TME, which also presents the largest depository of pathological landscape for HCC. This work highlights the potential of Kupffer cell-specific targeting rather than overall myeloid cell blocking as a novel immunotherapy for HCC treatment.Keywords
Funding Information
- National Key Research (2019YFA0803000, 2019YFC1316000)
- National Natural Science Foundation of China (81871925)
This publication has 53 references indexed in Scilit:
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinomaGut, 2015
- Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem CellsImmunity, 2015
- Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometryNature Methods, 2014
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiologyNature Communications, 2013
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine ResponsesImmunity, 2013
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2011
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasionCancer Immunology, Immunotherapy, 2006
- Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 2006
- Association of Vimentin overexpression and hepatocellular carcinoma metastasisOncogene, 2004